Sociedad Americana de Hirudoterapia

An increase in activity of serotonergic Retzius neurones may not be necessary for the consummatory phase of feeding in the leech Hirudo medicinalis.

Research article published in The Journal of experimental biology (1996)

Última actualización: 18 de junio de 2026Revisado por: ASH Editorial Board
Artículo de investigación — revisión de evidenciaReferencia del artículo
Evidence: Preclinical (animal)Genómica y proteómicaFarmacología salivalWilson et al. · The Journal of experimental biology, 1996

Abstract

During the consummatory phase of feeding, in which blood is ingested, medicinal leeches display a characteristic set of behaviours: they extend their jaws, are less responsive to sensory input, produce mucus, relax the body wall and exhibit waves of peristalsis that can run the length of the body. Earlier reports suggested that this pattern of behaviour is orchestrated by serotonin released from Retzius cells in response to the appropriate sensory stimulation of the lip. We have developed a semi-intact preparation in which only the nervous system in the posterior half of the leech was exposed. The front half of the leech was free to explore, bite through and feed until satiated from a blood-filled sausage casing while continuous intracellular and extracellular recordings were made from identified cells and the nerve roots of the exposed segments. Prior to attachment of the animal to the feeding device, the firing frequency of the Retzius cell increased transiently during spontaneous movements or tactile stimuli to its front or posterior end. In contrast, Retzius cell activity decreased after the anterior sucker attached to the membrane of the feeding device at about the time when ingestion was initiated. Increased activity of Leydig cells, which are known to modulate several circuits in the leech, was also associated with exploration. However, unlike that of Retzius cells, the activity of Leydig cells increased significantly following the onset of consumption. These results suggest that increased activity of Retzius cells in midbody ganglia is not a prerequisite for the consummatory phase of feeding and raises questions regarding the role of serotonin in regulating this behaviour.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal ArticleResearch Support, U.S. Gov't, Non-P.H.S.Research Support, U.S. Gov't, P.H.S.
Indexed MeSH termsAnimalsAppetitive BehaviorConsummatory BehaviorElectrophysiologyFeeding BehaviorGanglia, InvertebrateLeechesLeydig CellsMaleNeuronsSerotonin

Resumen

During the consummatory phase of feeding, in which blood is ingested, medicinal leeches display a characteristic set of behaviours: they extend their jaws, are less responsive to sensory input, produce mucus, relax the body wall and exhibit waves of peristalsis that can run the length of the body....

Por qué esto importa para la hirudoterapia

El resumen describe una preparación electrofisiológica en sanguijuelas medicinales en la que la mitad anterior se alimentaba de una envoltura de salchicha llena de sangre mientras se realizaban registros de neuronas y raíces nerviosas identificadas en el sistema nervioso posterior expuesto. Informa que la actividad de las células de Retzius disminuyó alrededor de la fijación y la ingestión, mientras que la actividad de las células de Leydig aumentó tras el inicio del consumo, lo que cuestiona la visión de que el aumento de la actividad de las células de Retzius/serotonina sea necesario para la fase consumatoria de la alimentación. El trabajo se refiere al comportamiento alimentario y la neuromodulación de las sanguijuelas. El resumen no menciona la hirudoterapia, el secretoma salival ni las aplicaciones terapéuticas, por lo que su relevancia para el ámbito clínico/terapéutico de ASH es insignificante.

Citación

An increase in activity of serotonergic Retzius neurones may not be necessary for the consummatory phase of feeding in the leech Hirudo medicinalis.

Wilson et al. · The Journal of experimental biology, 1996

Contexto clínico relacionado

Añadido a la biblioteca ASH: May 28, 2026 · Última actualización del sitio: 18 de junio de 2026

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.